Enorama Pharma AB (publ) (STO:ERMA)

Market Cap	28.64M -79.5%
Revenue (ttm)	2.74M -82.6%
Net Income	-75.14M
EPS	-1.08
Shares Out	74.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,911
Average Volume	98,711
Open	0.3540
Previous Close	0.4030
Day's Range	0.3300 - 0.3840
52-Week Range	0.2110 - 3.5800
Beta	1.74
RSI	41.21
Earnings Date	May 21, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 5
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ERMA

Financial Performance

In 2025, Enorama Pharma AB's revenue was 2.74 million, a decrease of -82.63% compared to the previous year's 15.77 million. Losses were -75.14 million, 71.5% more than in 2024.